| Pharmacological potential of cerium oxide nanoparticles I Celardo, JZ Pedersen, E Traversa, L Ghibelli Nanoscale 3 (4), 1411-1420, 2011 | 1156 | 2011 |
| Senescence and aging: the critical roles of p53 A Rufini, P Tucci, I Celardo, G Melino Oncogene 32 (43), 5129-5143, 2013 | 918 | 2013 |
| Ce3+ Ions Determine Redox-Dependent Anti-apoptotic Effect of Cerium Oxide Nanoparticles I Celardo, M De Nicola, C Mandoli, JZ Pedersen, E Traversa, L Ghibelli ACS nano 5 (6), 4537-4549, 2011 | 466 | 2011 |
| Class I HDACs share a common mechanism of regulation by inositol phosphates CJ Millard, PJ Watson, I Celardo, Y Gordiyenko, SM Cowley, ... Molecular cell 51 (1), 57-67, 2013 | 413 | 2013 |
| Mitofusin-mediated ER stress triggers neurodegeneration in pink1/parkin models of Parkinson’s disease I Celardo, AC Costa, S Lehmann, C Jones, N Wood, NE Mencacci, ... Cell death & disease 7 (6), e2271-e2271, 2016 | 180 | 2016 |
| Cerium oxide nanoparticles: a promise for applications in therapy I Celardo, E Traversa, L Ghibelli J Exp Ther Oncol 9 (1), 47-51, 2011 | 157 | 2011 |
| Unravelling mitochondrial pathways to P arkinson's disease I Celardo, LM Martins, S Gandhi British journal of pharmacology 171 (8), 1943-1957, 2014 | 125 | 2014 |
| Parp mutations protect against mitochondrial dysfunction and neurodegeneration in a PARKIN model of Parkinson’s disease S Lehmann, AC Costa, I Celardo, SHY Loh, LM Martins Cell death & disease 7 (3), e2166-e2166, 2016 | 83 | 2016 |
| dATF4 regulation of mitochondrial folate-mediated one-carbon metabolism is neuroprotective I Celardo, S Lehmann, AC Costa, SHY Loh, L Miguel Martins Cell Death & Differentiation 24 (4), 638-648, 2017 | 72 | 2017 |
| Caspase-1 is a novel target of p63 in tumor suppression I Celardo, F Grespi, A Antonov, F Bernassola, AV Garabadgiu, G Melino, ... Cell death & disease 4 (5), e645-e645, 2013 | 59 | 2013 |
| Drosophila ref (2) P is required for the parkin-mediated suppression of mitochondrial dysfunction in pink1 mutants IP De Castro, AC Costa, I Celardo, R Tufi, D Dinsdale, SHY Loh, ... Cell death & disease 4 (10), e873-e873, 2013 | 48 | 2013 |
| Parp mutations protect from mitochondrial toxicity in Alzheimer’s disease Y Yu, G Fedele, I Celardo, SHY Loh, LM Martins Cell Death & Disease 12 (7), 651, 2021 | 34 | 2021 |
| The immune system view of the coronavirus SARS-CoV-2 I Celardo, L Pace, L Cifaldi, C Gaudio, V Barnaba Biology Direct 15, 1-11, 2020 | 29 | 2020 |
| p53 regulates expression of nuclear envelope components in cancer cells E Panatta, A Butera, I Celardo, M Leist, G Melino, I Amelio Biology Direct 17 (1), 38, 2022 | 28 | 2022 |
| p63 transcriptionally regulates the expression of matrix metallopeptidase 13 I Celardo, A Antonov, I Amelio, M Annicchiarico-Petruzzelli, G Melino Oncotarget 5 (5), 1279, 2014 | 28 | 2014 |
| Commensal microbes and p53 in cancer progression I Celardo, G Melino, I Amelio Biology Direct 15 (1), 25, 2020 | 18 | 2020 |
| Suppression of intestinal dysfunction in a Drosophila model of Parkinson’s disease is neuroprotective G Fedele, SHY Loh, I Celardo, NS Leal, S Lehmann, AC Costa, ... Nature Aging 2 (4), 317-331, 2022 | 14 | 2022 |
| Enhancing folic acid metabolism suppresses defects associated with loss of Drosophila mitofusin J Garrido-Maraver, I Celardo, AC Costa, S Lehmann, SHY Loh, ... Cell Death & Disease 10 (4), 288, 2019 | 14 | 2019 |
| Combined transcriptomic and proteomic analysis of perk toxicity pathways R Popovic, I Celardo, Y Yu, AC Costa, SHY Loh, LM Martins International Journal of Molecular Sciences 22 (9), 4598, 2021 | 12 | 2021 |
| Definition of the neurotoxicity-associated metabolic signature triggered by berberine and other respiratory chain inhibitors I Suciu, J Delp, S Gutbier, J Suess, L Henschke, I Celardo, TU Mayer, ... Antioxidants 13 (1), 49, 2023 | 7 | 2023 |
